Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
Resmed announced it will release its third-quarter fiscal year 2025 financial and operational results on April 23, 2025, after the New York Stock Exchange closes. The company will host a webcast to discuss these results, which may include additional forward-looking and material information, potentially impacting stakeholders and providing insights into Resmed’s operational and market positioning.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed is a company that develops life-changing health technologies, focusing on AI-powered digital health solutions, cloud-connected devices, and intelligent software. Their products aim to make home healthcare more personalized, accessible, and effective, with a vision of improving sleep and breathing health for people in 140 countries.
YTD Price Performance: -2.89%
Average Trading Volume: 1,133,774
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$52.26B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.